⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

A

Agilent Technologies, Inc.

Healthcare · Diagnostics & Research

144.75USD

-2.1000 (-1.43%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.73▲$1.71103
Next quarter$1.5▼$1.5137
Current year$6.2▲$6.06180
Next year$6.76▲$6.6172

Recent quarters

Beat in 3 of the last 4

QuarterEstimateActualSurprise
2026-07-31$1.49$1.62+0.13 (+9.0%)
2026-04-30$1.41$1.49+0.08 (+5.8%)
2026-01-31$1.37$1.36-0.01 (-0.6%)
2025-10-31$1.58$1.59+0.01 (+0.4%)

Wall Street coverage

378 ratings from 37 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Wells FargoMaintainedOverweight$160 $180Aug 28, 2026
StifelMaintainedBuy$170 $180Aug 27, 2026
B of A SecuritiesMaintainedBuy$155 $180Aug 27, 2026
CitigroupMaintainedBuy$185 $190Aug 27, 2026
Goldman SachsMaintainedBuy$155 $175Aug 27, 2026
JP MorganMaintainedOverweight$180 $190Aug 27, 2026
TD CowenMaintainedBuy$155 $180Aug 27, 2026
BernsteinMaintainedOutperform$155 $180Aug 27, 2026
RBC CapitalMaintainedOutperform$155 $185Aug 27, 2026
Evercore ISI GroupMaintainedOutperform$148 $172Aug 27, 2026
BarclaysMaintainedOverweight$150 $175Aug 27, 2026
Morgan StanleyMaintainedOverweight$160 $175Aug 12, 2026
Evercore ISI GroupMaintainedOutperform$144 $148Jul 6, 2026
BarclaysMaintainedOverweight$145 $150Jun 24, 2026
Piper SandlerInitiated from OverweightNeutral$150Jun 11, 2026
HSBCMaintainedBuy$180 $165Jun 3, 2026
B of A SecuritiesMaintainedBuy$145 $155Jun 2, 2026
RBC CapitalMaintainedOutperform$153 $155May 28, 2026
TD CowenMaintainedBuy$147 $155May 28, 2026
BarclaysMaintainedOverweight$140 $145May 28, 2026
Wells FargoMaintainedOverweight$165 $160May 28, 2026
B of A SecuritiesUpgraded from NeutralBuy$150 $145May 28, 2026
RBC CapitalInitiatedOutperform$153May 27, 2026
BairdMaintainedOutperform$155 $156May 26, 2026
KeybancReiteratedSector Weight—Apr 28, 2026

Insider transactions

67 filings from 26 insiders · 11 buy / 1 sell over 6m

Officers and directors of A, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Dolsten MikaelDirectorSell634$151.38$96kSep 4, 2026
DOLSTEN MIKAELDirectorSell1.6k$135.42$217kMay 29, 2026
BUCKNER MICHAEL STEVENOfficerGrant8.9k——May 19, 2026
KOH BOON HWEEDirectorGrant2.2k$111.75$241kMar 19, 2026
BRAWLEY OTIS WDirectorGrant3.0k$111.75$340kMar 19, 2026
DOLSTEN MIKAELDirectorGrant2.2k$111.75$241kMar 19, 2026
RATAJ SUE HDirectorGrant2.2k$111.75$241kMar 19, 2026
WILSON DOW RDirectorGrant2.2k$111.75$241kMar 19, 2026
BROWN JUDY LYNNE GAWLIKDirectorGrant2.2k$111.75$241kMar 19, 2026
SCANGOS GEORGE ADirectorGrant3.2k$111.75$359kMar 19, 2026
ANAND MALADirectorGrant2.2k$111.75$241kMar 19, 2026
PODOLSKY DANIEL KDirectorGrant2.2k$111.75$241kMar 19, 2026
SORIOT PASCALDirectorGrant2.2k$111.75$241kMar 19, 2026
DOLSTEN MIKAELDirectorSell2.6k$149.81$390kDec 1, 2025
GONSALVES RODNEYOfficerGift400$154.37$62kNov 26, 2025
GONSALVES RODNEYOfficerSell3.0k$154.99$465kNov 26, 2025
DIMARCO BRET MOfficerGrant6.9k——Nov 18, 2025
GONSALVES RODNEYOfficerGrant4.9k——Nov 18, 2025
MCDONNELL PADRAIGChief Executive OfficerGrant40.4k——Nov 18, 2025
HENSON MEGHANOfficerGrant5.4k——Nov 18, 2025

Analyst Notes

Sign in to write

No analyst notes on A yet.

Analyst Ratings

20 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current412600Buy2.09
1 mo ago412600Buy2.09
2 mo ago512400Buy1.95
3 mo ago512300Buy1.90
Price target$175.45$155.00 – $190.00
+21.2% to target